Singapore insurance start-up Igloo lifts Series B to $46m
Singapore-based insurance technology start-up Igloo has added USD 27m to an initial USD 19m in Series B funding raised in March. Swiss impact investor BlueOrchard led the extension.
BlueOrchard is investing via its InsuResilience Investment Fund II, a joint venture with German development bank KfW that aims to address climate change by improving access to and the use of insurance...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.